Takeda Files 6-K
Takeda Pharmaceutical files periodic report with SEC. No details disclosed.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
Related stories
Ningbo Tuopu Q3 Net Profit Falls 4.8% Year Over Year
M impact | EQUITY | Oct 29, 2026, 09:36 AM UTC
MQ Technology Reports Q2 Revenue of 2.98 Million RGT
M impact | EQUITY | Oct 29, 2026, 09:36 AM UTC
Teck Resources' Q3 Adjusted Profit Jumps YoY
M impact | EQUITY | Oct 29, 2026, 09:36 AM UTC
ING Quarterly Profit Miss Dulls Impact of New Buyback Plan
ING's quarterly profit and total income missed expectations as the bank announced a fresh buyback plan.
M impact | EQUITY | Oct 29, 2026, 09:36 AM UTC
MQ Technology Reports Second-Quarter 2026 Results
For the quarter ended Aug. 31, revenue was MYR 2,978,000, versus MYR 2,187,000 a year earlier. Pretax profit figures are listed for 2026 and 2025.
M impact | EQUITY | Oct 29, 2026, 09:36 AM UTC
NetEase Files HKEX Disclosure Announcing Share Buyback
NetEase filed a next-day disclosure return with HKEX announcing a share buyback. The body says it repurchased 44 shares; no unit is specified.
L impact | EQUITY | Oct 29, 2026, 09:36 AM UTC